Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 179

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 179
---
University of Edinburgh. We believe that Mr. Lee is qualified to serve as our director because of his extensive experience in capital
markets.

Mr. Chun Fai Fong is an independent
director nominee and will serve as an independent director of the Company upon the effectiveness of the registration statement of which
this prospectus forms a part. Mr. Fong has been serving as the President of Mango Financial Limited since October 2024. From September
2023 to September 2024, he served as advisor (CFO) of 91360 Med Tech (Nanjing) Co., Ltd. From August 2021 to September 2023, he served
as head of corporate finance of Ping An of China Capital HK Ltd (a member of Ping An Insurance (Group) Company of China, Ltd.). From
October 2019 to January 2021, he served as head of corporate finance of CISI Capital Limited (a member of China Industrial Securities
International Financial Group Limited). From July 2010 to September 2017, he served in BOCI Asia Limited (a member of Bank of China Limited)
with the last position being the executive director of its investment banking department. From May 2005 to January 2009, he served BNP
Paribas (Asia Pacific) Limited with the last position as senior manager. From January 2004 to May 2005, he served as associate of ICEA
Capital Limited (a member of Industrial and Commercial Bank of China Limited). From June 2001 to December 2003, he served as staff accountant
of Ernst & Young Hong Kong. Mr. Fong obtained a bachelor’s degree of Actuarial Sciences from the University of Hong Kong in
2001 and was awarded with HSBC Hong Kong Bank Foundation Bursary. He has been a member of Hong Kong Institute of Certified Public Accountant
since 2005 and a member of corporate finance committee of Hong Kong Institute of Certified Public Accountants since 2018. We believe
that Mr. Fong is qualified to serve as our director because of his extensive experience in accounting and finance.

<div align='center'>100</div>

Mr. Kenrick B. Toussaint is an
independent director nominee and will serve as an independent director of the Company upon the effectiveness of the registration statement
of which this prospectus forms a part. Mr. Toussaint has been serving as the Director and Chairman of the audit committee of Bit Origin
(NASDAQ: B